Literature DB >> 16009959

Cetuximab and cisplatin for chemotherapy-refractory squamous cell cancer of the head and neck.

Barbara Burtness.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16009959     DOI： 10.1200/JCO.2005.02.002

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

Review 1.  Molecular therapy in head and neck oncology.

Authors:  Jacques Bernier; Søren M Bentzen; Jan B Vermorken
Journal:  Nat Rev Clin Oncol       Date:  2009-05       Impact factor: 66.675

2.  IKK phosphorylation of NF-κB at serine 536 contributes to acquired cisplatin resistance in head and neck squamous cell cancer.

Authors:  Zhipeng Li; Zejia Yang; Rena G Lapidus; Xuefeng Liu; Kevin J Cullen; Han C Dan
Journal:  Am J Cancer Res       Date:  2015-09-15       Impact factor: 6.166

Review 3.  Cardio-Oncology: Cancer Therapy-related Cardiovascular Complications in a Molecular Targeted Era: New Concepts and Perspectives.

Authors:  David Hurtado-de-Mendoza; Arturo Loaiza-Bonilla; Paula A Bonilla-Reyes; Gabriel Tinoco; Rodrigo Alcorta
Journal:  Cureus       Date:  2017-05-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.